BI_Providing professional financial news and data related to BI, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

Raybow Biotech - B (6938.HK): Achieves Third Key Milestone in MASH R&D Collaboration with Boehringer Ingelheim

Tags：

Raybow Biotech-B 06938.HK BI R&D collaboration

2026-05-06

Research
Daily Report on Hong Kong-Listed LLM Concept Stocks (July 1, 2026)
Finance
Shenghui Cleaning (02521.HK): Invests RMB 9,180,000 to Establish Joint Venture with Connected Party
Finance
Kindstar Globalgene Technology(09960.HK): Grant of 50,000 Share Options to One Employee
Finance
CSPC Pharmaceutical Group (01093.HK): Phase III Clinical Trial of SYS6010 Combined with Enlimomab as Adjuvant Therapy for NSCLC Officially Launched
Finance
Ocuvitas Therapeutics(01477.HK): Chief Financial Officer Yuen Tim Si Resigns; Chen Tingchan Appointed Sole Company Secretary and Authorised Representative
Finance
Chongqing Iron and Steel (01053.HK): Expected Net Loss of RMB 179 Million for First Half; Q2 Turns Profit Quarter-on-Quarter
Finance
DL Holdings (01709.HK): Zhao Meng Appointed as Non-executive Director, Qiao Linjian Resigns
Finance
KINGMAKER FOOTWEAR(01170.HK): Independent Non-executive Director Chan Mei Po to Retire, Wong Chiu Kwai Nominated as Successor
Finance
LongBio Pharma(01779.HK): Over-Allotment Option Fully Exercised, Raising Additional Net Proceeds of Approximately HK$194 Million
Finance
Ribo Life Science(06938.HK): Proposed Acquisition of 25.93% Equity Stake in Xingborun for RMB 70 Million

Scan QR Code

Download App